Mode
Text Size
Log in / Sign up
Phase 3 N=2,628 Randomized Quadruple-blind Treatment

CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia

Pneumonia

Enrolled (actual)
2,628
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Risk of Treatment Failure. — 267; 253 participants

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Zinc (Drug)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Centre For International Health
Primary completion
Jan 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Risk of Treatment Failure.
267; 253
PRIMARY
Non-injury Clinic Visits and Hospital Admissions After Treatment Has Been Initiated
PRIMARY
Active and Passive Morbidity Surveillance for Six Months After the 14-day Supplementation Period is Completed
PRIMARY
Difference in Growth and Thymic Size Between the Treatment Groups Measured at Three and Six Months After the Zinc Supplementation
PRIMARY
Adverse Effects
SECONDARY
Effect Modifiers for the Effect of Zinc Given During Pneumonia
SECONDARY
The Efficacy of Zinc According to Breast Feeding Status and in Different Age Categories
SECONDARY
The Efficacy of Zinc in Malnourished and Non-malnourished Children
SECONDARY
Will Presence of a RNA Virus Modify the Effect of Zinc
SECONDARY
Folate, Cobalamin and Vitamin D Status of the Enrolled Children

Summary

The aim of the study described is to measure the degree with which zinc given as adjunct therapy to standard antibiotic treatment during childhood pneumonia reduces the risk of treatment failure and the duration of the illness.

Eligibility Criteria

Inclusion Criteria

  • Pneumonia: Child presenting with cough or difficult breathing and elevated respiratory rate.
  • Severe pneumonia: Child presenting with cough or difficult breathing and chest indrawing , but without any of the following danger signs:
  • not able to drink/breastfeed,
  • vomit everything,
  • has had convulsions,
  • is lethargic or unconscious.
  • Must be able to take Zinc

Exclusion Criteria

  • The child requires special care for severe illness other than pneumonia
  • Severe malnutrition defined as being < 70% National Center for Health Statistics (NCHS) median weight for height
  • Presence of congenital heart disease
  • Documented tuberculosis
  • Any antibiotic treatment during the last 48 hours
  • The child was enrolled less than 6 months ago
  • Presence of dysentery
  • Cough for more than 14 days
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00148733). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search